questionsmedicales.fr
Mélanges complexes
Produits biologiques
Vaccins
Vaccins antiviraux
Vaccins antiviraux : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections virales
Tests diagnostiques
Vaccins antiviraux
Tests sérologiques
Symptômes
Vaccins antiviraux
Efficacité des vaccins
Études cliniques
Symptômes
5
Symptômes
Vaccins antiviraux
Effets secondaires
Vaccins antiviraux
Infections virales
Effets secondaires
Types de vaccins
Réponse immunitaire
Infections virales
Symptômes
Prévention
5
Prévention
Vaccins antiviraux
Vaccins antiviraux
Grossesse
Souches virales
Vaccins antiviraux
Vaccination de masse
Immunité collective
Traitements
5
Vaccins antiviraux
Traitements antiviraux
Antiviraux
Infections virales
Vaccins antiviraux
Symptômes
Vaccination
Traitements antiviraux
Vaccins antiviraux
Prévention
Complications
5
Complications
Réactions allergiques
Complications
Vaccins antiviraux
Gestion des complications
Vaccins antiviraux
Profils de complications
Vaccins antiviraux
Facteurs de risque
5
Facteurs de risque
Infections virales
Antécédents médicaux
Vaccination
Voyages
Infections virales
Personnes âgées
Complications
Mode de vie
Infections virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vaccins antiviraux : Questions médicales les plus fréquentes",
"headline": "Vaccins antiviraux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vaccins antiviraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-24",
"dateModified": "2025-02-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vaccins",
"url": "https://questionsmedicales.fr/mesh/D014612",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins",
"code": {
"@type": "MedicalCode",
"code": "D014612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-adénovirus",
"alternateName": "Adenovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D062705",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-adénovirus",
"code": {
"@type": "MedicalCode",
"code": "D062705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.024"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA",
"alternateName": "AIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D016915",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA",
"code": {
"@type": "MedicalCode",
"code": "D016915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la COVID-19",
"alternateName": "COVID-19 Vaccines",
"url": "https://questionsmedicales.fr/mesh/D000086663",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la COVID-19",
"code": {
"@type": "MedicalCode",
"code": "D000086663",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin ChAdOx1 nCoV-19",
"alternateName": "ChAdOx1 nCoV-19",
"url": "https://questionsmedicales.fr/mesh/D000090985",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin ChAdOx1 nCoV-19",
"code": {
"@type": "MedicalCode",
"code": "D000090985",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.063"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ad26COVS1",
"alternateName": "Ad26COVS1",
"url": "https://questionsmedicales.fr/mesh/D000090984",
"about": {
"@type": "MedicalCondition",
"name": "Ad26COVS1",
"code": {
"@type": "MedicalCode",
"code": "D000090984",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.085.125"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le cytomégalovirus",
"alternateName": "Cytomegalovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022482",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le cytomégalovirus",
"code": {
"@type": "MedicalCode",
"code": "D022482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.120"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la dengue",
"alternateName": "Dengue Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053059",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la dengue",
"code": {
"@type": "MedicalCode",
"code": "D053059",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.162"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie à virus Ebola",
"alternateName": "Ebola Vaccines",
"url": "https://questionsmedicales.fr/mesh/D046129",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie à virus Ebola",
"code": {
"@type": "MedicalCode",
"code": "D046129",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.205"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les herpèsvirus",
"alternateName": "Herpesvirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022283",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les herpèsvirus",
"code": {
"@type": "MedicalCode",
"code": "D022283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la varicelle",
"alternateName": "Chickenpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D019433",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la varicelle",
"code": {
"@type": "MedicalCode",
"code": "D019433",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre le zona",
"alternateName": "Herpes Zoster Vaccine",
"url": "https://questionsmedicales.fr/mesh/D053061",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre le zona",
"code": {
"@type": "MedicalCode",
"code": "D053061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.130.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus herpès simplex",
"alternateName": "Herpes Simplex Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022301",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus herpès simplex",
"code": {
"@type": "MedicalCode",
"code": "D022301",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie de Marek",
"alternateName": "Marek Disease Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022501",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie de Marek",
"code": {
"@type": "MedicalCode",
"code": "D022501",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.290.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antigrippaux",
"alternateName": "Influenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D007252",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antigrippaux",
"code": {
"@type": "MedicalCode",
"code": "D007252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.302"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre l'encéphalite japonaise",
"alternateName": "Japanese Encephalitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre l'encéphalite japonaise",
"code": {
"@type": "MedicalCode",
"code": "D022321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole",
"alternateName": "Measles Vaccine",
"url": "https://questionsmedicales.fr/mesh/D008458",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole",
"code": {
"@type": "MedicalCode",
"code": "D008458",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.404"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiourlien",
"alternateName": "Mumps Vaccine",
"url": "https://questionsmedicales.fr/mesh/D009108",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiourlien",
"code": {
"@type": "MedicalCode",
"code": "D009108",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.488"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les papillomavirus",
"alternateName": "Papillomavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053918",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les papillomavirus",
"code": {
"@type": "MedicalCode",
"code": "D053918",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"alternateName": "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18",
"url": "https://questionsmedicales.fr/mesh/D000068857",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin recombinant quadrivalent contre les papillomavirus humains de type 6, 11, 16 et 18",
"code": {
"@type": "MedicalCode",
"code": "D000068857",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.498.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus para-influenza",
"alternateName": "Parainfluenza Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022241",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus para-influenza",
"code": {
"@type": "MedicalCode",
"code": "D022241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antipoliomyélitiques",
"alternateName": "Poliovirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D023321",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antipoliomyélitiques",
"code": {
"@type": "MedicalCode",
"code": "D023321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique inactivé",
"alternateName": "Poliovirus Vaccine, Inactivated",
"url": "https://questionsmedicales.fr/mesh/D011054",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique inactivé",
"code": {
"@type": "MedicalCode",
"code": "D011054",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antipoliomyélitique oral",
"alternateName": "Poliovirus Vaccine, Oral",
"url": "https://questionsmedicales.fr/mesh/D011055",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antipoliomyélitique oral",
"code": {
"@type": "MedicalCode",
"code": "D011055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.623.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre la maladie d'Aujeszky",
"alternateName": "Pseudorabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022421",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre la maladie d'Aujeszky",
"code": {
"@type": "MedicalCode",
"code": "D022421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.632"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins antirabiques",
"alternateName": "Rabies Vaccines",
"url": "https://questionsmedicales.fr/mesh/D011819",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antirabiques",
"code": {
"@type": "MedicalCode",
"code": "D011819",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"alternateName": "Respiratory Syncytial Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022261",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les virus respiratoires syncytiaux",
"code": {
"@type": "MedicalCode",
"code": "D022261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.730"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-rotavirus",
"alternateName": "Rotavirus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022243",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-rotavirus",
"code": {
"@type": "MedicalCode",
"code": "D022243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antirubéoleux",
"alternateName": "Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012411",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antirubéoleux",
"code": {
"@type": "MedicalCode",
"code": "D012411",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"alternateName": "Measles-Mumps-Rubella Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022542",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin contre la rougeole, les oreillons et la rubéole",
"code": {
"@type": "MedicalCode",
"code": "D022542",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.779.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le SIDA simien",
"alternateName": "SAIDS Vaccines",
"url": "https://questionsmedicales.fr/mesh/D018449",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le SIDA simien",
"code": {
"@type": "MedicalCode",
"code": "D018449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.790"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antivariolique",
"alternateName": "Smallpox Vaccine",
"url": "https://questionsmedicales.fr/mesh/D012900",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antivariolique",
"code": {
"@type": "MedicalCode",
"code": "D012900",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.859"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre les hépatites virales",
"alternateName": "Viral Hepatitis Vaccines",
"url": "https://questionsmedicales.fr/mesh/D014761",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre les hépatites virales",
"code": {
"@type": "MedicalCode",
"code": "D014761",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite A",
"alternateName": "Hepatitis A Vaccines",
"url": "https://questionsmedicales.fr/mesh/D022362",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D022362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.395"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccins anti-hépatite B",
"alternateName": "Hepatitis B Vaccines",
"url": "https://questionsmedicales.fr/mesh/D017325",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins anti-hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D017325",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.955.400"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vaccins contre le virus du Nil occidental",
"alternateName": "West Nile Virus Vaccines",
"url": "https://questionsmedicales.fr/mesh/D053060",
"about": {
"@type": "MedicalCondition",
"name": "Vaccins contre le virus du Nil occidental",
"code": {
"@type": "MedicalCode",
"code": "D053060",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.962"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vaccin antiamaril",
"alternateName": "Yellow Fever Vaccine",
"url": "https://questionsmedicales.fr/mesh/D022341",
"about": {
"@type": "MedicalCondition",
"name": "Vaccin antiamaril",
"code": {
"@type": "MedicalCode",
"code": "D022341",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D20.215.894.899.970"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vaccins antiviraux",
"alternateName": "Viral Vaccines",
"code": {
"@type": "MedicalCode",
"code": "D014765",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yukai Huang",
"url": "https://questionsmedicales.fr/author/Yukai%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Xiao Guo",
"url": "https://questionsmedicales.fr/author/Xiao%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Yuancheng Zhou",
"url": "https://questionsmedicales.fr/author/Yuancheng%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Dongying Liu",
"url": "https://questionsmedicales.fr/author/Dongying%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Jingrui Mao",
"url": "https://questionsmedicales.fr/author/Jingrui%20Mao",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Short-, Mid-, and Long-term Strategies to Manage the Shortage of Iohexol.",
"datePublished": "2022-05-19",
"url": "https://questionsmedicales.fr/article/35587228",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1148/radiol.221183"
}
},
{
"@type": "ScholarlyArticle",
"name": "International Iohexol Shortage: Alternative Contrast Agents and Imaging Procedures for the Urologist.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/37103499",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/UPJ.0000000000000396"
}
},
{
"@type": "ScholarlyArticle",
"name": "GFR measurement in patients with CKD: Performance and feasibility of simplified iohexol plasma clearance techniques.",
"datePublished": "2024-07-17",
"url": "https://questionsmedicales.fr/article/39018289",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0306935"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of augmented renal clearance based on iohexol plasma clearance in critically ill children.",
"datePublished": "2023-11-23",
"url": "https://questionsmedicales.fr/article/37994980",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00467-023-06221-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Removal of carbamazepine, venlafaxine and iohexol from wastewater effluent using coupled microalgal-bacterial biofilm.",
"datePublished": "2022-09-10",
"url": "https://questionsmedicales.fr/article/36099989",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chemosphere.2022.136399"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Mélanges complexes",
"item": "https://questionsmedicales.fr/mesh/D045424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits biologiques",
"item": "https://questionsmedicales.fr/mesh/D001688"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vaccins",
"item": "https://questionsmedicales.fr/mesh/D014612"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vaccins antiviraux",
"item": "https://questionsmedicales.fr/mesh/D014765"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vaccins antiviraux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vaccins antiviraux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vaccins antiviraux",
"description": "Comment diagnostiquer une infection virale ?\nQuels tests sont utilisés pour les vaccins antiviraux ?\nLes symptômes indiquent-ils un besoin de vaccin ?\nComment évaluer l'efficacité d'un vaccin ?\nLes tests de dépistage sont-ils nécessaires avant vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Iohexol#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vaccins antiviraux",
"description": "Quels symptômes nécessitent un vaccin antiviral ?\nLes effets secondaires des vaccins sont-ils fréquents ?\nComment distinguer une infection d'un effet secondaire ?\nLes symptômes varient-ils selon le type de vaccin ?\nLes symptômes d'une infection virale sont-ils similaires ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Iohexol#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vaccins antiviraux",
"description": "Comment les vaccins antiviraux préviennent-ils les infections ?\nÀ quel âge doit-on commencer la vaccination antivirale ?\nLes vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?\nLes vaccins protègent-ils contre toutes les souches virales ?\nQuelle est l'importance de la vaccination de masse ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Iohexol#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vaccins antiviraux",
"description": "Les vaccins antiviraux sont-ils des traitements ?\nQuels traitements sont disponibles après infection ?\nLes vaccins peuvent-ils réduire la gravité des symptômes ?\nLes traitements sont-ils nécessaires après vaccination ?\nLes vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Iohexol#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vaccins antiviraux",
"description": "Quelles complications peuvent survenir après vaccination ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications post-vaccinales ?\nLes complications varient-elles selon le vaccin ?\nLes complications peuvent-elles affecter l'immunité ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Iohexol#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vaccins antiviraux",
"description": "Quels sont les facteurs de risque pour les infections virales ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes voyages augmentent-ils le risque d'infection ?\nLes personnes âgées ont-elles plus de risques ?\nLe mode de vie influence-t-il le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014765?mesh_terms=Iohexol#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests virologiques, des analyses sanguines et des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les vaccins antiviraux ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sérologiques et des cultures virales sont souvent utilisés pour évaluer l'immunité."
}
},
{
"@type": "Question",
"name": "Les symptômes indiquent-ils un besoin de vaccin ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre ou la fatigue peuvent indiquer une infection nécessitant un vaccin."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un vaccin ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques et des taux d'infection dans la population vaccinée."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils nécessaires avant vaccination ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests peuvent être recommandés pour certaines populations à risque avant la vaccination."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un vaccin antiviral ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la toux, la fièvre ou des douleurs musculaires peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Les effets secondaires des vaccins sont-ils fréquents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires comme la douleur au site d'injection sont courants mais généralement légers."
}
},
{
"@type": "Question",
"name": "Comment distinguer une infection d'un effet secondaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections présentent des symptômes persistants, tandis que les effets secondaires sont temporaires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de vaccin ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de vaccin et la réponse immunitaire individuelle."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection virale sont-ils similaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses infections virales partagent des symptômes comme la fièvre et la fatigue."
}
},
{
"@type": "Question",
"name": "Comment les vaccins antiviraux préviennent-ils les infections ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils stimulent le système immunitaire à reconnaître et combattre les virus spécifiques."
}
},
{
"@type": "Question",
"name": "À quel âge doit-on commencer la vaccination antivirale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge de vaccination dépend du vaccin, mais beaucoup commencent dès l'enfance."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils sûrs pour les femmes enceintes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vaccins sont sûrs pendant la grossesse, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Les vaccins protègent-ils contre toutes les souches virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins ciblent des souches spécifiques, et des mises à jour peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la vaccination de masse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination de masse aide à atteindre l'immunité collective et à réduire la propagation des virus."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux sont-ils des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins préviennent les infections, tandis que les traitements ciblent les infections existantes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles après infection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme l'oseltamivir peuvent être prescrits pour traiter certaines infections virales."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils réduire la gravité des symptômes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent atténuer la gravité des symptômes en cas d'infection post-vaccination."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils nécessaires après vaccination ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, mais des traitements peuvent être requis si une infection survient malgré la vaccination."
}
},
{
"@type": "Question",
"name": "Les vaccins antiviraux nécessitent-ils des traitements préventifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccins sont une mesure préventive, mais des traitements peuvent être nécessaires en cas d'exposition."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après vaccination ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications rares incluent des réactions allergiques sévères ou des syndromes neurologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la plupart des complications sont rares et les bénéfices de la vaccination l'emportent sur les risques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications post-vaccinales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un professionnel de santé pour évaluer et traiter les complications éventuelles."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le vaccin ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque vaccin peut avoir des profils de complications différents selon sa composition."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter l'immunité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent temporairement affecter la réponse immunitaire, mais cela est rare."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les infections virales ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les maladies chroniques, et l'immunodépression."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la vaccination ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de réactions allergiques ou de maladies peuvent influencer le choix du vaccin."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à risque peut augmenter l'exposition à des virus spécifiques."
}
},
{
"@type": "Question",
"name": "Les personnes âgées ont-elles plus de risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves liées aux infections."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant une bonne nutrition et de l'exercice, peut réduire le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Livestock and Poultry Biological Products Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutics, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, School of Basic Medicine, Zunyi Medical University, Zunyi, Guizhou, China.
Provincial Department of Education, Key Laboratory of Infectious Disease & Bio-Safety, Zunyi Medical University, Zunyi, Guizhou, China.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
Centre for Virus and Vaccine Research, Sunway University, Bandar Sunway, Malaysia.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. dailp@im.ac.cn.
Publications dans "Vaccins antiviraux" :
2 publications dans cette catégorie
Affiliations :
McMaster Immunology Research Centre and Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada. Electronic address: xingz@mcmaster.ca.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
, Rockville, MD, USA. halsteads@erols.com.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: Naina.mccann@paediatrics.ox.ac.uk.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford OX3 7LE, UK; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy; GSK, Siena, Italy.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: cristina.decastro@unina.it.
Publications dans "Vaccins antiviraux" :
1 publication dans cette catégorie
Publications dans "Vaccins antiviraux" :
The recent iohexol shortage has precipitated disruptions in a pharmaceutical supply chain critical to radiologic imaging and has impacted global availability of iodinated contrast media (ICM). The sho...
In April 2022, GE Healthcare announced a COVID-19-related interruption in iohexol manufacturing, leading to an international iodinated contrast shortage. The shortage greatly impacted urological pract...
A review of existing literature describing the use of alternative contrast agents, alternative imaging procedures, and contrast conservation strategies in urological care was performed using the PubMe...
Older iodinated contrast agents such as ioxaglate and diatrizoate can replace iohexol for intravascular imaging in patients without renal impairment. These agents, along with gadolinium-based agents s...
The COVID-19-related iohexol shortage caused significant hardship for urological care internationally, leading to delayed contrasted imaging studies and urological procedures. Alternative contrast age...
Implementing shortened one-compartment iohexol plasma clearance models for GFR measurement is crucial since the gold standard inulin renal clearance technique and the reference two-compartment, 10-hou...
Augmented renal clearance (ARC) holds a risk of subtherapeutic drug concentrations. Knowledge of patient-, disease-, and therapy-related factors associated with ARC would allow predicting which patien...
This is a retrospective analysis of data from the "IOHEXOL" study which validated GFR estimating formulas (eGFR) against CL...
Eighty-five patients were included; 57% were postoperative patients. Median CL...
Our findings raise PICU clinician awareness about increased risk for ARC after major surgery and in patients with eGFR above age-specific thresholds. This knowledge enables identification of patients ...
ClinicalTrials.gov NCT05179564, registered retrospectively on January 5, 2022....
We evaluated the removal capacity of a coupled microalgal-bacterial biofilm (CMBB) to eliminate three recalcitrant pharmaceuticals. The CMBB's efficiency, operating at different biofilm concentrations...
Maximum a posteriori Bayesian estimation (MAP-BE) based on a limited sampling strategy and a population pharmacokinetic model is frequently used to estimate pharmacokinetic parameters in individuals, ...
The objective of this work was to investigate the use of a hybrid machine learning/population pharmacokinetic approach to improve individual iohexol clearance estimation....
The reference iohexol clearance values were derived from 500 simulated profiles (samples collected between 0.1 and 24.7 h) using a population pharmacokinetic model we recently developed in Monolix and...
The MAP-BE limited sampling strategy estimated clearance was corrected by the machine learning predicted error leading to a decrease in root mean squared error by 29% and 24%, and in the percentage of...
In conclusion, this hybrid algorithm represents a significant improvement in comparison to MAP-BE estimation alone....
Barium sulfate and iohexol are commonly used as contrast agents for videofluoroscopic swallowing study (VFSS). This study compared their usefulness as contrast agents in visualizing components of swal...
Image guided nose-to-brain drug delivery provides a non-invasive way to monitor drug delivered to the brain, and the intranasal administration could increase effective dose via bypassing Blood Brain B...
Accurate renal function assessment is crucial to guide intensive care decision-making and drug dosing. Estimates of glomerular filtration rate (eGFR) are routinely used in critically ill children; how...
In this proof-of-concept study, eGFR formulas were found to be largely inaccurate in the PICU population. Clinicians should therefore use these formulas with caution to guide drug dosing and therapeut...
gov NCT05179564, registered retrospectively on January 5, 2022....
• Both acute kidney injury and augmented renal clearance may be present in PICU patients and warrant adaptation of therapy, including drug dosing. • Biomarker-based eGFR formulas are widely used for G...
• eGFR formulas were found to be largely inaccurate in the PICU population when compared to measured GFR by iohexol clearance. Clinicians should therefore use these formulas with caution to guide drug...
Acute kidney injury (AKI) and augmented renal clearance (ARC), both alterations of the glomerular filtration rate (GFR), are prevalent in critically ill children and neonates. AKI and ARC prevalence e...
In this single-center prospective study, critically ill term-born neonates and children were included. mGFR was calculated using a plasma disappearance curve after parenteral administration of iohexol...
One hundred five children, including 43 neonates, were included. AKI prevalence was higher based on mGFR (48%), than with KDIGO or eGFR (11-40%). ARC prevalence was lower with mGFR (24%) compared to e...
Iohexol-based AKI prevalence was higher and ARC prevalence lower compared to standard SCr-based eGFR methods. Age- and sex-dependent equations for eGFR (eGFR-Smeets for neonates and eGFR-Pierce for ch...